Christopher McKinney

Mr. McKinney joined Kohlberg in 2018. He is a member of the board of directors of Cadence, PCI Pharma Services, Trinity Life Sciences and Worldwide Clinical Trials. Prior to joining the Firm, Mr. McKinney was in the Industrials Group at Bank of America Merrill Lynch. Mr. McKinney received a B.S. from Boston College.